does glp-1 reduce inflammation therapy isn't just about appetite. It's about healing what's underneath The anti-inflammatory and immunological properties

This was because they were unconvinced an appropriate regulatory route could be found for proceeding with the substance for obesity

If youre reading this as an email, you may need to click expand or open in a new window to view in full

It shifts production from pheomelanin (yellow-red, UV-damaging) to eumelanin (brown-black, UV-protective) (Barnetson et al., 2006)

Gastrointestinal symptoms that some patients experience while on GLP-1 therapysuch as nausea, reduced appetite, or altered bowel habitsgenerally resolve as the medication clears from the system, typically within 1-2 weeks for short-acting formulations and within 4-8 weeks for long-acting preparations, corresponding to their elimination timelines